Two Sigma Advisers’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $783K | Buy |
|
|||||
|
2025
Q3 | $78K | Buy |
|
|||||
|
2025
Q2 | $15.1K | Sell |
|
|||||
|
2025
Q1 | $77.8K | Buy |
|
|||||
|
2024
Q4 | $103K | Sell |
|
|||||
|
2024
Q3 | $786K | Sell |
|
|||||
|
2024
Q2 | $878K | Sell |
|
|||||
|
2024
Q1 | $1.52M | Sell |
|
|||||
|
2023
Q4 | $1.36M | Buy |
|
|||||
|
2023
Q3 | $493K | Sell |
|
|||||
|
2023
Q2 | $604K | Sell |
|
|||||
|
2023
Q1 | $808K | Buy |
|
|||||
|
2022
Q4 | $1.13M | Buy |
|
|||||
|
2022
Q3 | $796K | Buy |
|